Dr. Robert E. Pluenneke, MD

Dr. Pluenneke practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Pluenneke's NPI, 1205808672, was assigned on February 1, 2006. Dr. Pluenneke graduated from University of Kansas School of Med (KC/Wich/Sal) in 1990. Dr. Pluenneke holds Missouri license 110145.

Dr. Pluenneke's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Pluenneke's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Pluenneke is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is KU Dental Associates. Dmand AI also links Dr. Pluenneke to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pluenneke practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pluenneke's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Pluenneke's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 1,610 Medicare services from Dr. Pluenneke across 8 procedure codes in 2024, for 356 Medicare patients. Medicare paid $109,665 for them.

CMS counts 356 Medicare patients who saw Dr. Pluenneke in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pluenneke's median patient age at 72, with 83% women.

In 2024, Dr. Pluenneke wrote 2,313 Medicare Part D claims for 287 patients. 85% of them were for generic drugs. CMS names the drug for 1,892 of them, across 56 drugs with 11 or more claims each, at $487,111 in total drug cost. In 2023, CMS named 1,763 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pluenneke for performance year 2024, reported through an alternative payment model (APM). Dr. Pluenneke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pluenneke as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Pluenneke from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Genentech, Inc. paid the most, $236.

Dr. Pluenneke graduated from University of Kansas School of Med (KC/Wich/Sal) in 1990.